Substitution monotherapy and add-on therapy were equally effective as a second-line treatment for women with idiopathic generalized epilepsy, with no significant differences in failure rates between ...

In patients with newly diagnosed epilepsy, nearly 70% of seizure relapses are linked to potentially modifiable factors, including poor adherence and inadequate ASM dosing, rather than drug resistance.

That may mean missed opportunities to prevent complications such as seizures, birth defects or poor neurodevelopmental outcomes. Women who saw a neurologist were far more likely to take recommended ...